This template is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.
This template is within the scope of WikiProject Chemicals, a daughter project of WikiProject Chemistry, which aims to improve Wikipedia's coverage of chemicals. To participate, help improve this template or visit the project page for details on the project.
In this template this drugs would act as agonist and antagonist; since its role as Beta-blocker, I would correct it. Emigiorg (talk) 14:36, 31 July 2012 (UTC)
Thanks for correcting that error! --ἀνυπόδητος (talk) 17:46, 31 July 2012 (UTC)
Semi-protected edit request on 15 September 2014[edit]
This edit request has been answered. Set the |answered= or |ans= parameter to no to reactivate your request.
Not done: it's not clear what changes you want to be made. Please mention the specific changes in a "change X to Y" format. EoRdE6(Come Talk to Me!) 14:44, 28 April 2015 (UTC)
Semi-protected edit request on 16 December 2015[edit]
This edit request has been answered. Set the |answered= or |ans= parameter to no to reactivate your request.
Xylometazoline is a α1 agonist too. 193.233.52.241 (talk) 08:24, 16 December 2015 (UTC)
Done Anon126 (notify me of responses! / talk / contribs) 05:50, 15 September 2014 (UTC)
Done 
Not done: it's not clear what changes you want to be made. Please mention the specific changes in a "change X to Y" format. EoRdE6(Come Talk to Me!) 14:44, 28 April 2015 (UTC)
Not done: it's not clear what changes you want to be made. Please mention the specific changes in a "change X to Y" format. 
